<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01106924</url>
  </required_header>
  <id_info>
    <org_study_id>08.22 NRC</org_study_id>
    <nct_id>NCT01106924</nct_id>
  </id_info>
  <brief_title>Effects of a Probiotic on Body Weight</brief_title>
  <official_title>Effects of Consumption of a Probiotic Formulation on Weight Control in Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics administration is associated with health benefits on gut barrier integrity and&#xD;
      immunological functions of the gastrointestinal tract. Recently, probiotics consumption was&#xD;
      proposed to reduce fat mass and body weight in rodents (Lee HY. et al. 2006; Hamad EM. et al.&#xD;
      2009) as well as abdominal fat in human (Kadooka Y, 2010). The mechanisms explaining the&#xD;
      effects of probiotics in weight control are not well understood.&#xD;
&#xD;
      The primary objective of the clinical trial is to investigate whether a consumption of a&#xD;
      probiotic formula when compared to an intake of a placebo, is associated with a greater&#xD;
      reduction of body weight.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight; Body composition (DEXA); Waist circumference</measure>
    <time_frame>PRE and POST</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>daily probiotic consumption</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>daily placebo consumption</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>daily probiotic consumption</description>
    <arm_group_label>Probiotic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>daily placebo consumption</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: between 18 and 55 years old&#xD;
&#xD;
          -  Weight: 30.0 kg/m2 ≤ BMI ≤ 39.9 kg/m2&#xD;
&#xD;
          -  Non smokers&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  A 2 weeks probiotics washout period prior to treatment initiation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under antibiotics or treatments (medication or nutritional program) affecting body&#xD;
             weight or glucose control for the last 3 months&#xD;
&#xD;
          -  Currently participating or having participated in another clinical trial during the&#xD;
             last 6 months prior to the beginning of this study&#xD;
&#xD;
          -  Pregnant women, women who have given birth in the past year, women planning pregnancy&#xD;
             in the next 6 months or menopausal women&#xD;
&#xD;
          -  Excessive consumption of products enriched in probiotics (&gt; 4 servings per week).&#xD;
&#xD;
          -  History of drug or alcohol (&gt; 2 drinks daily) abuse&#xD;
&#xD;
          -  Abnormal thyroid hormone levels&#xD;
&#xD;
          -  Intake of medication that could affect body weight and/or energy expenditure&#xD;
&#xD;
          -  Family history of type 2 diabetes in first degree relatives&#xD;
&#xD;
          -  Allergy to the ingredients in the study product and placebo&#xD;
&#xD;
          -  Participant with anaemia&#xD;
&#xD;
          -  Participant with a recent history of large weight fluctuations (e.g., &gt; 10 kg in the&#xD;
             past year&#xD;
&#xD;
          -  Immune-compromised conditions&#xD;
&#xD;
          -  Participant experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal&#xD;
             pain&#xD;
&#xD;
          -  Participant with co-morbidity associated with obesity:&#xD;
&#xD;
               -  Hypertension (≥ 140/90 mm Hg)&#xD;
&#xD;
               -  Current use of antihypertensive medications, depression&#xD;
&#xD;
               -  Prediabetes (fasting glucose &gt;100mg/dL)&#xD;
&#xD;
               -  Family history of premature coronary artery disease&#xD;
&#xD;
               -  LDL &gt; 2.0 mmol/L&#xD;
&#xD;
               -  HDL &lt; 1.3 mmol/L&#xD;
&#xD;
               -  Smoking&#xD;
&#xD;
               -  Obstructive sleep apnea&#xD;
&#xD;
               -  Type 2 diabetes&#xD;
&#xD;
               -  Cardiovascular disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laval University and Laval Hospital</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>April 19, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2010</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Probiotics, Weight control, Body composition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

